Federal contract award
HT001425P0034
CLONOSEQ HAS RECEIVED CLEARANCE FROM THE FOOD AND DRUG ADMINISTRATION FOR AN IN VITRO DIAGNOSTIC TEST SERVICE THAT DETECTS BLOOD CANCER IN PATIENTS.
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Defense |
| Office | DEFENSE HEALTH AGENCY |
| NAICS | 621511 — Medical Laboratories |
| PSC | Q301 — Reference Laboratory Testing |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $44.9K |
| Current contract value | $44.9K |
| Potential contract value / ceiling | $224.2K |
| Start date | Feb 28, 2025 |
| Current end date | Feb 27, 2026 |
| Potential end date | Feb 27, 2030 |
| Latest award activity | Nov 26, 2025 |
| Source loaded | Sep 19, 2026 |
Funding and modification history
Showing the latest 4 of 4 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Nov 26, 2025 | P00003 | $0 | CLONOSEQ IS FOOD AND DRUG ADMINISTRATION APPROVED FOR AN IN VITRO DIAGNOSTIC TESTING SERVICE THAT DETECTS BLOOD CANCER IN PATIENTS. |
| Mar 7, 2025 | P00002 | $0 | CLONOSEQ HAS RECEIVED CLEARANCE FROM THE FOOD AND DRUG ADMINISTRATION FOR AN IN VITRO DIAGNOSTIC TEST SERVICE THAT DETECTS BLOOD CANCER IN PATIENTS. |
| Feb 28, 2025 | 0 | $44.9K | CLONOSEQ HAS RECEIVED CLEARANCE FROM THE FOOD AND DRUG ADMINISTRATION FOR AN IN VITRO DIAGNOSTIC TEST SERVICE THAT DETECTS BLOOD CANCER IN PATIENTS. |
| Feb 28, 2025 | P00001 | $0 | CLONOSEQ HAS RECEIVED CLEARANCE FROM THE FOOD AND DRUG ADMINISTRATION FOR AN IN VITRO DIAGNOSTIC TEST SERVICE THAT DETECTS BLOOD CANCER IN PATIENTS. |
Estimated positioning window
Feb 27, 2029 – Aug 27, 2029
40/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 40/100. Available recorded signals: 35 points.
- Contract end 2030-02-27 (1221 days from calculation)
- +5 points
- 13 historical awards in this buyer and category group
- +15 points
- 4 recorded award transactions
- +10 points
- Latest award action: 2025-11-26
- +5 points
- Parent award identifier recorded
- +0 points
- Solicitation identifier recorded
- +0 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-10-25 10:18:04.631876+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Oct 25, 2026.
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Verify whether remaining options may extend performance beyond the current end date.
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.